Estimation of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease

被引:35
|
作者
Spithoven, Edwin M. [1 ]
van Gastel, Maatje D. A. [1 ]
Messchendorp, A. Lianne [1 ]
Casteleijn, Niek F. [1 ]
Drenth, Joost P. H. [2 ]
Gaillard, Carlo A. [1 ]
de Fijter, Johan W. [3 ]
Meijer, Esther [1 ]
Peters, Dorien J. M. [4 ]
Kappert, Peter [5 ]
Renken, Remco J. [6 ]
Visser, Folkert W. [1 ]
Wetzels, Jack F. M. [7 ]
Zietse, Robert [8 ]
Gansevoort, Ron T. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, NL-9713 AV Groningen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands
[3] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands
[4] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands
[8] Erasmus MC, Dept Nephrol, Rotterdam, Netherlands
关键词
Autosomal dominant polycystic kidney disease (ADPKD); total kidney volume (TKV); magnetic resonance imaging (MRI); estimation methods; ellipsoid; PANK; validation; ADPKD; PROGRESSION; TOLVAPTAN; TRIALS; DESIGN;
D O I
10.1053/j.ajkd.2015.06.017
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In autosomal dominant polycystic kidney disease (ADPKD), obtaining measured total kidney volume (mTKV) by magnetic resonance (MR) imaging and manual tracing is time consuming. Two alternative MR imaging methods have recently been proposed to estimate TKV (eTKV(ellipsoid) and eTKV(PANK)), which require less time. Study Design: Cross-sectional and longitudinal diagnostic test study. Setting & Participants: Patients with ADPKD with a wide range of kidney function and an approved T2-weighted MR image obtained at the University Medical Centers of Groningen, Leiden, Nijmegen, and Rotterdam, the Netherlands, in 2007 to 2014. Test set for assessing reproducibility, n = 10; cohort for cross-sectional analyses, n = 220; and cohort for longitudinal analyses, n = 48. Index Tests: Average times for eTKV(ellipsoid) and eTKV(PANK) were 5 and 15 minutes, respectively. Bias is defined as (mTKV - eTKV)/mTKV x 100%; precision, as one standard deviation of bias. Reference Tests: mTKV using manual tracing to calculate the area within kidney boundaries times slice thickness. Average time for mTKV was 55 minutes. Results: In the test set, intra- and intercoefficients of variation for mTKV, eTKV(ellipsoid), and eTKV(PANK) were 1.8% and 2.3%, 3.9% and 6.3%, and 3.0% and 3.4%, respectively. In cross-sectional analysis, baseline mTKV, eTKV(ellipsoid), and eTKV(PANK) were 1.96 (IQR, 1.28-2.82), 1.93 (IQR, 1.25-2.82), and 1.81 (IQR, 1.17-2.62) L, respectively. In cross-sectional analysis, bias was 0.02% +/- 3.2%, 1.4% +/- 9.2%, and 4.6% +/- 7.6% for repeat mTKV, eTKV(ellipsoid), and eTKV(PANK), respectively. In longitudinal analysis, no significant differences were observed between percentage change in mTKV (16.7% +/- 17.1%) and percentage change in eTKV(ellipsoid) (19.3% 6 16.1%) and eTKV(PANK) (17.8% +/- 16.1%) over 3 years. Limitations: Results for follow-up data should be interpreted with caution because of the limited number of patients. Conclusions: Both methods for eTKV perform relatively well compared to mTKV and can detect change in TKV over time. Because eTKV(ellipsoid) requires less time than eTKV(PANK), we suggest that this method may be preferable in clinical care. (C) 2015 by the National Kidney Foundation, Inc.
引用
收藏
页码:792 / 801
页数:10
相关论文
共 50 条
  • [21] Autosomal dominant polycystic kidney disease
    Chow, Chern Li
    Ong, Albert C. M.
    CLINICAL MEDICINE, 2009, 9 (03) : 278 - 283
  • [22] Autosomal dominant polycystic kidney disease
    Lanktree, Matthew B.
    Chapman, Arlene B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (45) : E1396 - E1396
  • [23] AUTOSOMAL DOMINANT POLYCYSTIC DISEASE OF THE KIDNEY
    FICK, G
    WEBER, M
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (30) : 1160 - 1164
  • [24] Autosomal Dominant Polycystic Kidney Disease
    Zacharia, George Sarin
    Rajakumari, P. K.
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2013, 3 (04): : 194 - 195
  • [25] Autosomal dominant polycystic kidney disease
    Silverman, Jonathan
    Desai, Chaitanya
    Lerma, Edgar V.
    DM DISEASE-A-MONTH, 2015, 61 (10): : 442 - 447
  • [26] Autosomal dominant polycystic kidney disease
    Cornec-Le Gall, Emilie
    Alam, Ahsan
    Perrone, Ronald D.
    LANCET, 2019, 393 (10174): : 919 - 935
  • [27] Autosomal dominant polycystic kidney disease
    Pirson, Y
    Chauveau, D
    Watson, ML
    Zeier, M
    Breuning, MH
    M S-MEDECINE SCIENCES, 1997, 13 (01): : 37 - 44
  • [28] Autosomal dominant polycystic kidney disease
    Beebe, DK
    AMERICAN FAMILY PHYSICIAN, 1996, 53 (03) : 925 - 931
  • [29] Autosomal dominant polycystic kidney disease
    Torres, Vicente E.
    Harris, Peter C.
    Pirson, Yves
    LANCET, 2007, 369 (9569): : 1287 - 1301
  • [30] AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Pljesa, Steva
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2008, 136 : 340 - 347